Advanced BioScience Laboratories, Inc (ABL) 是馬里蘭州的生物醫學研究公司,專責為生物醫學團體提供資源開發和評估各種疫苗,治療和診斷傳染源。ABL是一個高度專業的合同研究組織(CRO ),具有與政府,商業和其他團體合作的豐富經驗。ABL致力于預防艾滋病毒和傳染病的研究。ABL可以幫助各個領域的產品開發,包括:基礎研究,疫苗或產品設計,具有免疫調控的動物模型,為*階段和第二階段的臨床試驗生產cGMP生物制品以及許多其他服務。
ABL有著數以百計的出版物和在艾滋病毒和傳染病領域幾十年的研究經驗。
ABL有著悠久的歷史,為客戶提供免疫調控服務( ELISA方法,抗原表位的映射,免疫印跡,淋巴細胞的分離,流式細胞儀, elispot等) ,細胞庫,并擴增和QC病毒(HIV, SIV, Vaccinia, CMV, HTLV, and FIV)和雜交瘤。
ABL還可以提供一系列廣泛的病毒學檢測方法的研究使用,如通過NASBA進行RNA的病毒載量測試,抗病毒和病毒中和試驗,RIPA,抗原捕獲,檢測的RT和其它許多相關服務。
ABL還針對HIV,SIV和病毒學研究提供各種特殊產品,包括抗體,抗原,高免疫血清,病毒原液和抗原捕獲試劑盒。
Advanced BioScience Laboratories, Inc.報價表 | ||||
貨號 | 品名 | 包裝 | 價格 | 品牌 |
5421 | HIV-1 p24 Antigen Capture Assay | 96t | 5310 | ABL |
2855 | Vaccinia Virus Titration In BSC-1 Cells | Each | 詢價 | ABL |
2859 | Preparation of Vaccinia (From client provided seed) | Each | 詢價 | ABL |
2910 | Native Human IL-2 (640 IU/mL) | 50mL | 2880 | ABL |
2911 | Native Human IL-2 (320 IU/mL) | 50mL | 1710 | ABL |
3231 | Direct Pellet (100x) | 1mL | 詢價 | ABL |
3232 | Single Band in Sucrose Gradient (10,000x) | 1mL | 詢價 | ABL |
3236 | HIV-1 IIIB (Prostak) | 1mL | 133740 | ABL |
3237 | HTLV-I | 1mL | 詢價 | ABL |
3238 | SIV-1 | 1mL | 詢價 | ABL |
4300 | Anti-p21E (Envelope) | 100ug | 3420 | ABL |
4301 | Anti-gp120 Env (Broadly Reactive) | 100ug | 3420 | ABL |
4302 | Anti-gp120 Env (C2 Domain, Reacts with Types M and O) | 100ug | 3420 | ABL |
4303 | Anti-gp120 Env (Type O) | 100ug | 3420 | ABL |
4304 | Anti-gp41 Env (Type O) | 100ug | 3420 | ABL |
4305 | Anti-Tat | 100ug | 3420 | ABL |
4310 | Anti-p24 Gag (Capsid Protein) | 100ug | 3420 | ABL |
4311 | Anti-gp120 (Conformational) | 100ug | 3420 | ABL |
4312 | Anti-gp41 Env | 100ug | 3420 | ABL |
4313 | Anti-p24 Gag | 100ug | 3420 | ABL |
4314 | Anti-p17 Gag (Cross Reacts with p55) | 100ug | 3420 | ABL |
4315 | Anti-p66/51 (RT) | 100ug | 3420 | ABL |
4317 | Anti-gp120 Env (aa307 to 320) | 100ug | 3420 | ABL |
4318 | Anti-gp120 Env (aa 35 to 108) | 100ug | 3420 | ABL |
4322 | Anti-gp32 Env (Weakly Nuetralizing) | 100ug | 3420 | ABL |
4323 | Anti-p27 Gag | 100ug | 3420 | ABL |
4324 | Anti-p27 Gag (Cross Reacts with HIV-1/2) | 100ug | 3420 | ABL |
4325 | Anti-p17 Gag | 100ug | 3420 | ABL |
4326 | Anti-gp120 Env | 100ug | 3420 | ABL |
4327 | Anti-gp120 Env (Neutralizing) | 100ug | 3420 | ABL |
5407 | Anti-p17 Gag from Rabbit | 1ml | 6210 | ABL |
5408 | Anti-gp120 Env (Clade E, Isolate 93TH976) from Rabbit | 1ml | 6210 | ABL |
5411 | Anti-gp120 Env (Clade C, Isolate 96ZM651) from Rabbit | 1ml | 6210 | ABL |
5412 | Anti-p24 Gag from Rabbit | 1ml | 4680 | ABL |
5413 | Anti-gp120 Env (mac251) from Rabbit | 1ml | 6210 | ABL |
5414 | Anti-gp120 Env (Clade B, Isolate IIIB) from Rabbit | 1ml | 6210 | ABL |
5415 | Anti-tat from Rabbit | 1ml | 6210 | ABL |
5416 | Anti-nef from Rabbit | 1ml | 6210 | ABL |
5417 | Anti-HTLV-I p24 Gag from Goat | 1ml | 4680 | ABL |
5418 | Anti-HTLV-I p24 Gag from Rabbit | 1ml | 4680 | ABL |
5419 | Anti-gp120 Env (Clade A, Isolate 92UG037) | 1ml | 6210 | ABL |
5420 | Anti-gp120 Env (Clade B, Isolate Ba-L) from Rabbit | 1ml | 6210 | ABL |
5422 | Anti-gp120 Env (Clade D, Isolate 57140) from Rabbit | 1ml | 6210 | ABL |
5423 | HIV-1 IIIB gp120 (Native) | 100ug | 16650 | ABL |
5424 | HIV-1 451 gp120 (Native) | 100ug | 15570 | ABL |
5425 | HIV-1 IIIB p24 | 100ug | 9090 | ABL |
5426 | HIV-1 IIIB gp140 (Native) | 100ug | 15570 | ABL |
5427 | HIV-1 451 gp140 (Native) | 100ug | 15570 | ABL |
5428 | SIV mac251 gp120 (Native) | 100ug | 15570 | ABL |
5429 | HIV-1 gp120 Antigen Capture Assay | 96t | 11160 | ABL |
5430 | SIV mac251 p27 (Native) | 100ug | 9360 | ABL |
5436 | SIV p27 Antigen Capture Assay | 96t | 6210 | ABL |
5441 | HIV-1 IIIB Biologically Active TAT (Recombinant) | 1 mg | 52848 | ABL |
5442 | HIV-1 IIIB Biologically Active TAT (Recombinant) | 100ug | 5292 | ABL |
5447 | Bulk HIV-1 p24 | 10x96t | 42750 | ABL |
5450 | Bulk SIV p27 | 10x96t | 53910 | ABL |